» Articles » PMID: 1710634

A Rapid and Simple Method for Measuring Thymocyte Apoptosis by Propidium Iodide Staining and Flow Cytometry

Overview
Publisher Elsevier
Date 1991 Jun 3
PMID 1710634
Citations 996
Authors
Affiliations
Soon will be listed here.
Abstract

Corticosteroids, calcium ionophores and anti-CD3 monoclonal antibodies kill mouse thymocytes incubated in vitro. Cell death is preceded by extensive DNA fragmentation into oligonucleosomal subunits. This type of cell death (apoptosis), which physiologically occurs in the intrathymic process of immune cell selection, is usually evaluated by either electrophoretic or colorimetric methods which measure DNA fragmentation in the nuclear extracts. These techniques are unable to determine the percentage of apoptotic nuclei or recognize the apoptotic cells in a heterogeneous cell population. We have developed a flow cytometric method for measuring the percentage of apoptotic nuclei after propidium iodide staining in hypotonic buffer and have compared it with the classical colorimetric and electrophoretic techniques using dexamethasone (DEX)-treated mouse thymocytes. Apoptotic nuclei appeared as a broad hypodiploid DNA peak which was easily discriminable from the narrow peak of thymocytes with normal (diploid) DNA content in the red fluorescence channels. When the DEX-induced apoptosis was inhibited by either low-temperature (4 degrees C) incubation or cycloheximide treatment, no hypodiploid DNA peak appeared. Similarly, thymocyte death induced by sodium azide, a substance with cell-killing activity through non-apoptotic mechanisms, did not result in any variation in the normal DNA peak. The flow cytometric data showed an excellent correlation with the results obtained with both electrophoretic and colorimetric methods. This new rapid, simple and reproducible method should prove useful for assessing apoptosis of specific cell populations in heterogeneous tissues such as bone marrow, thymus and lymph nodes.

Citing Articles

A New Light-Sensor System Affecting Cancer Cell Fate.

Buonvino S, Arciero I, Moretti S, Iorio E, Melino S Biomater Res. 2025; 29:0157.

PMID: 40046560 PMC: 11880576. DOI: 10.34133/bmr.0157.


Inhibition of DYRK1B BY C81 impedes inflammatory processes in leukocytes by reducing STAT3 activity.

Ciurus S, Elewa M, Palmer M, Wolf A, Hector M, Fuhrmann D Cell Mol Life Sci. 2025; 82(1):85.

PMID: 39985685 PMC: 11846820. DOI: 10.1007/s00018-025-05579-y.


Design, Synthesis and Molecular Modeling of Pyrazolo[1,5-]pyrimidine Derivatives as Dual Inhibitors of CDK2 and TRKA Kinases with Antiproliferative Activity.

Attia M, Lasheen D, Samir N, Taher A, Abdel-Aziz H, Abou El Ella D Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770509 PMC: 11678221. DOI: 10.3390/ph17121667.


Novel 4-alkoxy Meriolin Congeners Potently Induce Apoptosis in Leukemia and Lymphoma Cells.

Krings K, Wassenberg T, Cea-Medina P, Schmitt L, Lechtenberg I, Llewellyn T Molecules. 2025; 29(24.

PMID: 39770138 PMC: 11676355. DOI: 10.3390/molecules29246050.


Tonabersat enhances temozolomide-mediated cytotoxicity in glioblastoma by disrupting intercellular connectivity through connexin 43 inhibition.

Schmidt E, Evert B, Pregler B, Melhem A, Hsieh M, Raspe M Mol Oncol. 2024; 19(3):878-898.

PMID: 39680504 PMC: 11887680. DOI: 10.1002/1878-0261.13786.